Mannose-binding lectin 2 in cystic fibrosis

S. Crovella, C. Trevisiol, F. Poli, I. Giuseppin (Trieste, Italy)

Source: Annual Congress 2005 - Cystic fibrosis lung disease: let's make things better
Session: Cystic fibrosis lung disease: let's make things better
Session type: Poster Discussion
Number: 4630
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Crovella, C. Trevisiol, F. Poli, I. Giuseppin (Trieste, Italy). Mannose-binding lectin 2 in cystic fibrosis. Eur Respir J 2005; 26: Suppl. 49, 4630

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of mannose-binding lectin variant alleles among cystic fibrosis patients in Italy
Source: Eur Respir J 2002; 20: Suppl. 38, 339s
Year: 2002

Mannose-binding lectin and IgG receptor polymorphisms in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 1s
Year: 2001

Impact of mannose-binding lectin deficiency on clinical course of cystic fibrosis in Southern Italy
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

Ficolins and mannose-binding lectin in Danish patients with sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008



Mannose binding lectin deficiency is associated with disease severity in patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Mannose-binding lectin (MBL) insufficiency in children with chronic obstructive pulmonary disease post-adenovirus infection (COPDadv)
Source: Eur Respir J 2006; 28: Suppl. 50, 585s
Year: 2006

Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Stable non-cystic fibrosis bronchiectasis is associated with deficiency of the pattern recognition molecule L-Ficolin
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


CFTR: cystic fibrosis and beyond
Source: Eur Respir J 2014; 44: 1042-1054
Year: 2014



LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient
Source: Eur Respir J 2002; 19: 374-376
Year: 2002



Inhibition of airway proteases in cystic fibrosis lung disease
Source: Eur Respir J 2008; 32: 783-795
Year: 2008



Diabetes as a determinant of renal impairment in adult cystic fibrosis (CF)
Source: Eur Respir J 2007; 30: Suppl. 51, 387s
Year: 2007

Children with cystic fibrosis are MBL deficient or not?
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008

Relevance of mannose-binding lectin (MBL) polymorphism in repeated respiratory infections
Source: Eur Respir J 2001; 18: Suppl. 33, 465s
Year: 2001

Comorbidities in cystic fibrosis
Source: International Congress 2015 – Comorbidities in COPD and other chronic lung diseases
Year: 2015



Genotype-specific small-molecule therapy for cystic fibrosis
Source: Breathe 2013; 9: 176-186
Year: 2013


Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006

Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009